2013中华医学会铜绿假单胞菌下呼吸道感染诊治专家共识

2013-09-30 dxy dxy

铜绿假单胞菌假单胞菌(Pseudomonas aeruginosa,P. aeruginosa,PA)是一种革兰阴性杆菌,也是临床最常见的非发酵菌,在自然界广泛分布,可作为正常菌群在人体皮肤表面分离到,还可污染医疗器械甚至消毒液,从而导致医源性感染,是医院获得性感染重要的条件致病菌,具有易定植、易变异和多耐药的特点。 下呼吸道是院内感染最常见的发生部位,主要包括支气管扩张、慢性阻塞性肺疾病(CO

铜绿假单胞菌假单胞菌(Pseudomonas aeruginosa,P. aeruginosa,PA)是一种革兰阴性杆菌,也是临床最常见的非发酵菌,在自然界广泛分布,可作为正常菌群在人体皮肤表面分离到,还可污染医疗器械甚至消毒液,从而导致医源性感染,是医院获得性感染重要的条件致病菌,具有易定植、易变异和多耐药的特点。

下呼吸道是院内感染最常见的发生部位,主要包括支气管扩张、慢性阻塞性肺疾病(COPD)合并感染和肺炎,由多重耐药PA(multidrug resistant P aeruginosa,MDR-PA)引起的下呼吸道感染病死率高,治疗困难,因此规范PA肺部感染的诊断和治疗具有重要意义。

原文下载

中华医学会呼吸病学分会感染学组.铜绿假单胞菌下呼吸道感染诊治专家共识 2013.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1844419, encodeId=26a018444191c, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Wed Aug 27 13:19:00 CST 2014, time=2014-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282355, encodeId=5d97128235599, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Wed Oct 02 04:19:00 CST 2013, time=2013-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486524, encodeId=d7b41486524fa, content=<a href='/topic/show?id=43e320132fa' target=_blank style='color:#2F92EE;'>#下呼吸道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20132, encryptionId=43e320132fa, topicName=下呼吸道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4608143316, createdName=循证小兵, createdTime=Wed Oct 02 04:19:00 CST 2013, time=2013-10-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1844419, encodeId=26a018444191c, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Wed Aug 27 13:19:00 CST 2014, time=2014-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282355, encodeId=5d97128235599, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Wed Oct 02 04:19:00 CST 2013, time=2013-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486524, encodeId=d7b41486524fa, content=<a href='/topic/show?id=43e320132fa' target=_blank style='color:#2F92EE;'>#下呼吸道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20132, encryptionId=43e320132fa, topicName=下呼吸道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4608143316, createdName=循证小兵, createdTime=Wed Oct 02 04:19:00 CST 2013, time=2013-10-02, status=1, ipAttribution=)]
    2013-10-02 zhmscau
  3. [GetPortalCommentsPageByObjectIdResponse(id=1844419, encodeId=26a018444191c, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Wed Aug 27 13:19:00 CST 2014, time=2014-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282355, encodeId=5d97128235599, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Wed Oct 02 04:19:00 CST 2013, time=2013-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486524, encodeId=d7b41486524fa, content=<a href='/topic/show?id=43e320132fa' target=_blank style='color:#2F92EE;'>#下呼吸道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20132, encryptionId=43e320132fa, topicName=下呼吸道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4608143316, createdName=循证小兵, createdTime=Wed Oct 02 04:19:00 CST 2013, time=2013-10-02, status=1, ipAttribution=)]

相关资讯

慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(草案)

慢性阻塞性肺疾病(chronic obstructive pulmonary  disease,COPD)简称慢阻肺,是一种严重危害人类健康的常见病、多发病。我国对7个地区20  245名成年人进行调查,40岁以上人群中慢阻肺患病率高达8.2%。世界银行,世界卫生组织的资料表明,到2020年慢阻肺将位居世界疾病经济负担的第5位,全球死亡原因的第3位。慢阻肺患者每年约发生0.5~

降压治疗保护血管功能中国专家共识

      降压治疗保护血管功能中国专家共识 本文专家组组长胡大一    随着影像学与计算机技术的进步,直接无创、重复测量动脉血管的结构与功能已成为可能。结构的检测除了测量斑块的数量与大小之外还包括测量动脉血管内径大小、整个或部分血管壁厚度比如主动脉内徑、表浅动脉内膜中层厚度以及小动脉腔壁比值等。这些检测指标可以用于评

研究汇总:转移瘤不可切除的晚期结直肠癌原发瘤切除的共识与争议

转移瘤不可切除的同时性晚期结直肠癌(mCRC)是指确诊结直肠癌的同时,患者已经伴发远处转移,而且转移瘤在技术上或肿瘤学上被认为不能切除。转移瘤是否可切除,是晚期结直肠癌是否能治愈的重要标准,而对于不可切除者,疾病已属于不能治愈,治疗原则就是控制症状、改善生活治疗,延长患者生存,因此,主要的治疗是全身化疗。 而在考虑原发灶是否应该切除时,主要看原发灶是否伴有症状,主